Metraipolis › archive › dc_87166dba294a

Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg-positive chronic hepatitis B patients during Peg-IFN-α therapy — Europe PMC PMID:42440527

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42440527
DOI
10.3389/fphar.2026.1844257
License (as archived)
solo-consultazione
Archived
2026-10-19T06:45:00.840Z
SHA-256 of the archived text
7765b20999941c42b6a6889352e68b5860ec58e4eb755a16b830b70315f95989
Stable URL of this page
https://metraipolis.com/documento/dc_87166dba294a

How to cite

Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg-positive chronic hepatitis B patients during Peg-IFN-α therapy — Europe PMC PMID:42440527 — Europe PMC (en), https://europepmc.org/article/MED/42440527 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_87166dba294a (Metraipolis archive dc_87166dba294a, sha256 7765b20999941c42b6a6889352e68b5860ec58e4eb755a16b830b70315f95989)
BibTeX
@misc{dc87166dba294a,
  title = {Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg-positive chronic hepatitis B patients during Peg-IFN-α therapy — Europe PMC PMID:42440527},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440527},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_87166dba294a; sha256 7765b20999941c42b6a6889352e68b5860ec58e4eb755a16b830b70315f95989},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440527. Agents can read the archived copy with the MCP tool read_document.